Loading candles…
Caplin Point Laboratories Ltd, incorporated in 1990, is an Indian pharmaceutical company operating primarily through a 100% export-oriented business model. The company engages in manufacturing and sourcing active pharmaceutical ingredients (APIs), finished pharmaceutical formulations including ointments and creams, as well as research and development and clinical research. It owns distribution networks and focuses on serving markets in Latin America, Francophone Africa, the USA, Canada, Australia, Mexico, Brazil, and other countries. Caplin Point has a dominant presence in Latin America and Francophone Africa and is expanding its footprint in regulated markets such as the USA, Canada, Australia, Mexico, and Brazil. Its approach combines ownership of distribution networks with targeting the Bottom of the Pyramid market segment within the pharmaceutical industry.
This page is a live market overview for CAPLIN POINT LAB LTD. (CAPLIPOINT) on the NSE. As a listed security, CAPLIN POINT LAB LTD. is tracked in the Healthcare segment of the Indian cash market and is widely followed for price discovery, liquidity and sector exposure. Use this overview to review price action, session ranges and derivatives context for CAPLIPOINT before placing trades on tick2trade.
As of the latest feed, CAPLIPOINT last traded at ₹2,574.1 on NSE, down ₹11.7 (0.45%) from the previous close of ₹2,585.8. Today's session range is ₹2,556.7 – ₹2,597.6, against a 52-week band of ₹1,500.3 – ₹2,699. Traded volume today stands at 44.43K shares.
The overview consolidates an interactive price chart with multiple time ranges, recent market headlines, upcoming corporate events for CAPLIPOINT in one place so you do not need multiple screens during the session. Day and 52-week ranges help you judge whether CAPLIPOINT is trading near support, resistance or the middle of its recent band. Volume and depth, when available, add context on how aggressively the name is being bought or sold.
Equity overview pages are built for investors who want a single reference for CAPLIN POINT LAB LTD. before reading news, checking results or sizing a position. Corporate events and headlines in the side column surface catalysts that may explain sudden moves in CAPLIPOINT. Related stocks in the same sector appear at the bottom of the page for quick peer comparison.
For a full option chain with greeks, open-interest bias, max pain and multi-leg strategy tools, open the tick2trade terminal or visit the dedicated CAPLIPOINT option chain page linked from this overview.
| Type | Details | Date |
|---|---|---|
| Results - FY26 | To consider and approve the financial results for the period ended June 30, 2026 and to recommend final dividend | 12 Aug 2026 |
| Results - FY26 | To consider and approve the financial results for the period ended March 31, 2026 and declaration of dividend, if any. | 14 May 2026 |
| Unaudited Results - FY25 | To consider and approve the unaudited financial results for the period ended December 31, 2025 | 5 Feb 2026 |
| Results - FY25 | To consider and approve the financial results for the period ended September 30, 2025 | 5 Nov 2025 |
| Results - FY25 | To consider and approve the financial results for the period ended Jun 30, 2025 and dividend | 7 Aug 2025 |
| Audited Results - FY25 | To consider and approve the annual audited financial results of the company for the period ended March 31, 2025 and declaration of interim dividend. | 15 May 2025 |
Tick2trade is a brand/platform owned and operated by Besseggen InfoTech LLP, a SEBI Registered Stock Broker holding Registration No: INZ000213450, Member of NSE (Member Code: 90155) and BSE (Member Code: 6722). Investment in securities market are subject to market risks; read all related documents carefully before investing.